Roche Pharmaceuticals A/S: Financial statements 2013
CVR: 25230515
Source: annual report 2013, Danish Business Authority
01/01/2013 – 31/12/2013
Roche Pharmaceuticals A/S (CVR 25230515) has filed annual accounts for 2013. In 2013, the company reported revenue of DKK 689,754,000 and a net result of DKK 14,505,000. The profit margin was 2.1%. Equity in the 2013 report amounted to DKK 88,573,000. The solvency ratio was 29.3%. The company had 103 employees in the financial year.
- Revenue
- DKK 689,754,000
- Gross Profit
- DKK 128,943,000
- Profit/Loss
- DKK 14,505,000
- Equity
- DKK 88,573,000
- Total Assets
- DKK 302,800,000
- Employees
- 103
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2013
As of September 1, 2013, Jennifer Elizabeth Cook has joined the board of directors of Roche Pharmaceuticals A/S.
As of September 1, 2013, Peter Hug has left the board of directors of Roche Pharmaceuticals A/S.
Roche Pharmaceuticals A/S has published its annual report for 2012.
About Roche Pharmaceuticals A/S
Roche Pharmaceuticals A/S is a Danish company of the type Aktieselskab based in København V, founded in 1970. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named ROCHE A/S. MEDICINALVARER & KEMIKALIER. The management consists of Carole Hassoun. The board consists of Isabel Marianne Joerin (chair), Carole Hassoun and Ehab Abdelmoneim Youssef Hassan. The company is owned by Roche Holding AG. The company has 96 employees (2026). In 2025, the company reported revenue of DKK 928,824,000 and a net result of DKK 31,319,000 compared with DKK 24,277,000 the year before. Equity in the 2025 report amounted to DKK 195,179,000.